Description of goals of treating atrial fibrillation. Rhythm vs rate control and anticoagulation.
Просмотров: 831 Diego Belardi
In this video we try to explain two of the key issues for the management of atrial fibrillation. 1.The first issue is the issue of heart rate control versus heart rhythm control. Will your physician try to just control your heart rate or try to flip your rhythm back in to sinus rhythm from atrial fibrillation? With heart rate control our goal is to try to control the heart rate only. Thus the patient could still be in atrial fibrillation however heart rate is brought under control (60-110 bpm) with medications like beta blockers- metoprolol and calcium channel blockers like diltiazem etc. By rhythm control the physician tries to reset the heart into into sinus rhythm from atrial fibrillation. This can be done with the help of medications and is called as chemical cardioversion. Or it can be done by electrical shock also known as electrical cardioversion. Medications that can be used to keep the patient in the rhythm. These medications include, flecanide, sotalol or amiodarone etc. 2. The second key issue in the management of atrial fibrillation is prevention of stroke. Stroke is a deadly complication of atrial fibrillation. The first question that arises is what is the risk of stroke in a given patient with atrial fibrillation. A patients risk of stroke can be calculated by using an abbreviation called CHAD2VASC2 (explained in the table). Blood thinners (like Coumadin or newer agents like xeralto/apixaban/rivaroxaban) are recommended for patients with a score more than 2. For a score of zero usually no blood are recommended and for patients with the score of one either blood thinner or are aspirin as recommended. If you like this video and would like to see more of such patient educational videos go to our website www.patienteducationpro.com.
Просмотров: 1639 PatientEducationPro
Anne O'Connor, MD and Jennifer Wright, MD co-present a lecture about clinical management of atrial fibrillation. Dr. O'Connor is an Associate Professor (CHS) whose clinical interests include critical cardiology, reducing readmissions for heart failure and acute myocardial infarct patients, and cardiovascular imaging. Dr. Wright is a Clinical Assistant Professor who specializes in cardiology and electrophysiology. Both are members of the Division of Cardiovascular Medicine in the Department of Medicine at UW-Madison. The title of their June 16, 2017 Grand Rounds talk is "Atrial Fibrillation: Can We Organize the Chaos?" University of Wisconsin Department of Medicine Grand Rounds are presented throughout the academic year and are intended for health care professionals and medical researchers. Unless otherwise indicated, Grand Rounds occurs in the William S. Middleton Memorial Veterans Hospital auditorium, Room A1028, Madison, Wisconsin. All faculty and staff are invited and encouraged to attend. For more information on the Grand Rounds lecture series, visit http://www.medicine.wisc.edu/dom/medicine-grand-rounds
Просмотров: 2441 UW Department of Medicine
"New Anticoagulants for Stroke Prevention in Atrial Fibrillation" Christian Ruff, MD Treatment Options for Atrial Fibrillation and VTE March 4th, 2013 Brigham and Women's Hospital Boston, MA
Просмотров: 10931 NAThrombosisForum
T271 Canadian Cardiovascular Society Atrial Fibrillation Guidelines Management of AF for the family physician Dr Alan Bell (1)
Просмотров: 443 CFPCMedia
😀 Learn fast with Dr. Aman Arora's videos! 🌎 Website: https://aroramedicaleducation.co.uk #aroraBites #CanPassWillPass #iWentWithArora ------------------------------------- 👌 This video: 💥💥💥 60 seconds on when you may consider rhythm-control for AF instead of rate-control Source/details: https://cks.nice.org.uk/atrial-fibrillation#!scenarioclarification *not for medical advice* --------------------------------------- 🙋♂️ Find out more about Dr. Aman: (https://aroramedicaleducation.co.uk/meet-aman/) 🙌 JOIN DR. AMAN ON HIS OTHER STREAMS FOR MORE FREE MEDICAL EDUCATION: 😳 Busy? Subscribe to #aroraCondensed: Aman’s fortnightly teaching emails direct to your inbox: http://eepurl.com/duAwXr ✅ Flagship Facebook Medical Education group: (https://www.facebook.com/groups/aroraMedicalExamSupport/) ✅ Facebook Page: (https://www.facebook.com/arorameded/) ✅ Instagram: @dr_aman_arora (https://www.instagram.com/dr_aman_arora/) ✅ Twitter: @aman999arora (https://mobile.twitter.com/aman999arora) ✅ SoundCloud: Dr Aman Arora (https://soundcloud.com/user-121278599) -------------------------------- 🌎 Website: https://aroramedicaleducation.co.uk 💥 Immersion Courses 💥 Mock Exams 💥 Live Webinars 💥 Audiobooks 💥 Online Training 💥 One-to-one Sessions 💥 Questions and Cases 💥 Revision Posters ----------------------------------- *All videos are for educational purposes only and are not to be used for medical advice* *No medical advice can be given on this channel - appropriate qualified medical advice should be sought for clinical or healthcare queries* *Guidance is aimed to be relevant and up-to-date at time of release*
Просмотров: 1121 Aman Arora
Atrial fibrillation including management
Просмотров: 80 Azib Zahid
Speaker: A/Prof Ching Chi Keong Date: 28th February 2016
Просмотров: 139 SEMSingapore
Teresa Tsang, MD, FRCPC, FACC, FASE, Vancouver, BC; John Cairns, MD, FRCPC, FRCP (Lond), FCAHS, FACC;Jason Andrade, MD, FRCPC Atrial fibrillation (AF) is the most common arrhythmia managed by physicians. Most patients with AF or atrial flutter (AFL) have poor quality of life due to the symptomatology of the disease, making the management strategy a key component of symptoms improvement, reduction of hospitalizations, and prevention of further complications, such as stroke. The Canadian Cardiovascular Society (CCS) Atrial Fibrillation Guidelines Program has generated a comprehensive series of documents regarding the management of AF between 2010 and 2016.
Просмотров: 12079 CFPCMedia
Houston Methodist DeBakey Heart & Vascular Center Grand Rounds “Rate Control versus Rhythm Control for Atrial Fibrillation” Fred Morady, MD October 6, 2016
Просмотров: 1642 DeBakey Institute For Cardiovascular Education & Training
Ashwani Bedi, M.D., FHRS: Striving for Curative Atrial Fib Management Types of atrial fibrillation, update on anticoagulation with Dr. Brayton, treatment options, more.
Просмотров: 201 Northern California Medical Associates
Rate and Rhythm Control for Atrial Fibrillation Gregory Piazza, MD North American Thrombosis Forum (NATF) Thrombosis Prevention Forum 2011 April 28, 2011 Boston, MA
Просмотров: 1449 NAThrombosisForum
This is me getting Atrial Fibrillation Treatment 10 years ago. Had to get cardioverted after an episode of Afib - After having an episode, the doctors gave me a whats called a Cardioversion Procedure. It is given by injecting propofol (milk of amnesia). While in a sleep state brought on by this drug... the doctors would shock my heart until it would go back into normal sinus rhythm. I posted this video because I thought it might help people who are concerned about Atrial Fibrillation. My first episode occurred when I was 33, in 2003. It happened spontaneously and has altered the way I live my life. The doctors prescribed Sotalol and Coumadin -- one to regulate my heart rhythm, the other to prevent my blood from clotting in case I had another episode. When atrial fibrillation occurs, blood pools in your heart chambers which can cause clotting, which in turn can result in stroke or even death. No matter which drugs the doctors prescribed, it was not successful in keeping my heart out of Atrial Fibrillation. It happened on the average of every three months. The only way my to get my heart back to normal rhythm was to have a cardioversion each time. This procedure is shown in the video above. I had actually enjoyed the experience. It was a short euphoric feeling, then sleep, which seemed to last only seconds. By the time I awoke, 20 to 30 minutes would have gone by. After having cardioversion 7 times, I asked a nurse to video the procedure. I never remembered any pain or yelling out. Seeing this video really upset me and I decided to have a cardio ablation (a procedure where doctors go in through your veins to cauterize the synapse nodes that regulate your heart beat.) The doctors had told me about this procedure but recommended I wait until the technology was better. At the time this was all happening to me the success rate was 80 percent. However, I decided I wanted to take my chances. I had the operation in 2007 and was one of the lucky 80 percent. I haven't had an episode of afib since. I'm glad to see all the interest this video stirred. I look back now and realize the experience was somewhat of a gift. I now live a much healthier life and have a deeper appreciation for the air I breathe. Please feel free to comment and share your experiences or ask me any questions about mine.
Просмотров: 651730 FreddyFish
An in-depth conversation between Pentucket Medical cardiologists Seth Bilazarian and Sunny Srivastava, focusing on a newly released medicine to reduce the risks of atrial fibrillation. The latest among recently approved blood thinners, Eliquis joins Pradaxa and Xarelto as an alternative to Coumadin, a drug that has been in use since the 1950s. Like Pradaxa and Xarelto, Eliquis has been shown to reduce risk of stroke and bleeding, as well as mortality. All the new drugs eliminate the need for regular blood testing that Coumadin necessitates.
Просмотров: 29133 PentucketMedical
In a video originally posted on TheHeart.org, Win-Kuang Shen, MD, sits down with Samuel J Asirvatham, MD, and Douglas Packer, MD, for an in-depth discussion of the major issues involved in managing atrial fibrillation, from increasing patient awareness to stroke prevention and when and how to use ablation.
Просмотров: 761 Mayo Clinic
Atrial fibrillation is a common heart condition that causes an irregular and often rapid heart rate. Control of heart rate can be achieved with different medications, but we currently lack evidence for the best treatment, making it difficult to choose the right medication for individual patients. The RATE-AF trial is designed to compare two strategies of rate-control, to see which improves quality of life and heart function. Patients with atrial fibrillation are closely involved with the design and management of the research study. Together, we hope to improve the lives of patients with atrial fibrillation and give doctors more evidence about how to treat their patients. For more information, please go to http://www.birmingham.ac.uk/rateaf. RATE-AF is sponsored by the University of Birmingham and funded through a Fellowship programme by the National Institute for Health Research (NIHR), a UK government body that coordinates and funds research for the National Health Service. Video filmed and edited by Daniel Coley and Sarah Tholin (University of Birmingham). Music by Podington Bear: http://freemusicarchive.org/music/Podington_Bear/Joyful/PeasCorps
Просмотров: 496 RATE-AF
Dr. Alo discusses atrial fibrillation treatment algorithms including many of the newer rate and rhythm control drugs. Also discusses the novel anticoagulation options. Target audience is informed patients and medical professionals. hhtp://MohammedAlo.com
Просмотров: 10948 Mohammed Alo
Rich Gordon and Dan McCollum discuss differences between treating Atrial Fibrillation with rapid ventricular response with rate control versus cardioversion. Rich favors rhythm control a bit more than Dan who slightly prefers rate control. Rich makes some excellent points about the need to resuscitate to maintain correct rhythm and to remember the use of heparin if you plan to cardiovert.
Просмотров: 1633 Daniel McCollum
While warfarin has long been a common treatment option for patients with atrial fibrillation new medications are coming to the market which provide different benefits than the original option.
Просмотров: 3521 MD Magazine
Title: Atrial Fibrillation: Epidemiology & Warfarin for Stroke Prevention
Просмотров: 1368 NAThrombosisForum
Type 1 and type 2 AF Most medical conditions in the western world are caused by one or more of the following conditions: Age Genetics Luck and Lifestyle. Lets look at diabetes. There is type 1 diabetes which is usually caused by bad genetics or just bad luck and affects young patients and there is type 2 diabetes which affects older patient and is usually caused by age and lifestyle. They are managed differently. Type 1 diabetes is treated with Insulin Type 2 diabetes is treated with tablets/diet and sometimes insulin (and lifestyle changes) In the same way, i believe that there are 2 types of Afib and they are caused by different things but unfortunately they are thought of as one condition and therefore all Afib is managed in the same way but ideally they should be managed differently and if you understand the difference, it may allow you to target those treatments which will give you most benefit. Type 1 Afib. Whilst most patients with Afib is seen in older patients with comorbidities, we do see it in younger patients who have no comorbidites…this has historically been termed lone Afib. In these patients, the reason of Afib is usually genetic or bad luck when you scan these patients they have normal sized left atria and often their Afib comes and goes and interestingly they seem to really not tolerate their Afib very well at all. When you follow them up, they have an exceptionally good prognosis with no increase in stroke risk and these patients seem to respond extremely well to ablation. Type 2 Afib, Older patients with Afib usually tend to develop it because of increased age and bad lifestyle. They often have comorbidites such as diabetes, hypertension, sleep apnoea and vascular disease. Interestingly when you scan their hearts they have big sized left atria and they seem to tolerate their Afib very well. Often many are found to be in Afib incidentally and they are often in persistent Afib. When you follow them up, they do very badly in the short to medium term and have a much higher incidence of strokes, heart failure and even sudden death and therefore need anticoagulation. Often they don’t respond as well to ablation and even if they do they often end up requiring more than one procedure and taking away the Afib does not alter their risk of strokes or overall prognosis. and therefore I think that patients with type 1 Afib should be treated with reassurance and ablation and patients with type 2 A fib do better with anticoagulation and lifestyle modification and ablation in the case of refractory symptoms
Просмотров: 7048 York Cardiology
This video explains how atrial fibrillation (AF) can cause stroke and why anticoagulation is so important to prevent this. It features AF Association CEO, Trudie Lobban MBE, Deputy CEO, Jo Jerrome, CEO of Anticoagulation Europe, Eve Knight and leading AF specialist, Professor John Camm. Developed in association with Boehringer Ingelheim
Просмотров: 1399 ArrhythmiaAlliance
Reviews what is atrial fibrillation (afib), how common is afib, what causes afib, how afib causes stroke, what is the risk of stroke with afib, how to calculate your risk of stroke with afib, how to reduce chances of stroke with atrial fibrillation, what is coumadin, what are the risks of coumadin, what are the new anticoagulants available in the market today to treat afib, occlusion devices, when is an occlusion device indicated, the Watchman device, the Lariat Device, what are the symptoms of afib, medications for afib symptoms including amiodarone, the risks of amiodarone, risks and benefits of antiarrhythmics, what is an afib ablation, how are atrial fibrillation ablations done, what is the benefit of an afib abaltion. Written by two cardiologists: Dr. Jorge Romero MD FACC FHRS, electrophysiologist, and Dr. José Taveras MD FACC. Produced by Doctablet. You can find the post for this video at: https://doctablet.com/medicine/cardiology/arrhythmina/afib/afib-series/ Please visit Doctablet for more topics that will supplement the information you see in this video: https://doctablet.com/ Also! You can ask questions related to this topic, we enjoy answering questions, it helps us get feedback and gives us material for future videos. ALSO!, most important! Subscribe to our YouTube Channel! It means the world to https://www.youtube.com/channel/UCiGhz8d21xvPWs7FgLx2sMFA/?sub_confirmation=1
Просмотров: 432 Doctablet
Dr. Marc Gillinov discussed the results of a CSTN study looking at rate control vs. rhythm control after cardiac surgery – and – the takeaways for clinicians treating post-operative atrial fibrillation.
Просмотров: 571 Cleveland Clinic
Dr. S Arthnari performs on The main cause of strokes in the elderly is acquired Aortic Stenosis
Просмотров: 24 Revolution Talk
Dr David Whalley, Cardiologist at Royal North Shore Hospital, talks about the medical management of atrial fibrillation. Presentation delivered at the Structural Heart Disease Australia Left Atrium Symposium 23 July 2016.
Просмотров: 709 Structural Heart Disease Australia
Dr. Rajat Deo, a cardiovascular medicine doctor at Penn Heart and Vascular, discusses how new and better drugs will be replacing Coumadin to help atrial fibrillation patients avoid strokes. These drugs have fewer side effects and less of a need for careful monitoring. Learn more about the services at Penn Heart and Vascular: http://www.pennmedicine.org/heart/patient/clinical-services/ View Dr. Rajat Deo's profile: http://www.pennmedicine.org/wagform/mainpage.aspx?config=provider&p=pp&id=11092 Dr. Deo was interviewed by Andrew Schorr, host and founder of Patient Power, at the 2010 American Heart Association (AHA) annual meeting.
Просмотров: 1048 Penn Medicine
Atrial fibrillation (AF) increases stroke risk five-fold. This video explains how this risk could be reduced through appropriate anticoagulation. It features Arrhythmia Alliance and AF Association CEO, Trudie Lobban MBE, AF Association Deputy CEO, Jo Jerrome, leading heart rhythm specialist, Professor John Camm and CEO of Anticoagulation Europe, Eve Knight. Developed in association with Boehringer Ingelheim.
Просмотров: 2288 ArrhythmiaAlliance
http://www.stopafib.org StopAfib.org interviews Dr. Eric Prystowsky of St. Vincent's Hospital in Indianapolis, Indiana Find more on Dr. Prystowsky: http://www.stopafib.org/newsitem.cfm/NEWSID/417 Find more on rate control for the treatment of afib at: http://www.stopafib.org/rate-control.cfm In this video, Dr. Prystowsky discussed the proper application of rate control as a method of controlling atrial fibrillation, as well as which patients may be most appropriately treated with rate control. Dr. Prystowsky currently serves as the Director of the Clinical Electrophysiology Laboratory at St. Vincent's Hospital, and as a Consulting Professor of Medicine at Duke University. He is a former President of the Heart Rhythm Society, and is one of the leading clinical cardiac electrophysiologists in the world.
Просмотров: 3528 StopAfib
Hey, this is Dr. Jack Wolfson, The Paleo Cardiologist of The Drs. Wolfson and obviously I am a board certified cardiologist and I have a lot of people from all over the world that come to see me for atrial fibrillation. And... very often when it comes to blood thinners and atrial fibrillation and stroke and atrial fibrillation, patients are very confused. I wanna set the record straight for them and really help them make an educated decision as far as what is right for them. One of the first things I do with my patients when they have atrial fibrillation and they are concerned about stroke risks or they've been prescribed pharmaceutical blood thinners such as Warfarin, otherwise known as COUMADIN, or one of the newer drugs like PRADAXA or XARELTO, I show them this website, and it's called chadsvasc.org and you can see it up here on my screen on the top left. On Chadsvasc you can go there and you can actually get lots of different information and you can figure out what your stroke risk is, and then you and your doctor can decide what's right for you. Let's take a look over here where you plug in your risk factors. So you go through this check list. Congestive heart failure, if you do have congestive heart failure as identified by this criteria, then you would give yourself a point... and so on and so forth. If you've got hypertension, or if you are on pharmaceuticals for hypertension/high blood pressure, you get a point. Age greater than 75 gets ya two points. 65 to 74 gets ya one point. Diabetes gets ya one. Stroke or TIA, by history, gets ya two points. History of vascular disease, like if you've had angioplasty, a stint, or previous bypass surgery, that gets you a point and if you are female, you get a point. So, say for example, let's take Jack Wolfson. I am 46 years old. I have never had a history of congestive heart failure. Never had hypertension. My age, I'm 46. No diabetes. No history of stroke. No history of vascular disease and I am a male. So, my score is a zero. So we go over to into this side and we see Chadsvasc score of zero. My chances of having a stroke are zero percent, If I was in full-time atrial fibrillation. We are not going to make it much lower than zero percent with any form of pharmaceuticals. Well now, let's just take the 67 year old female patient with hypertension. So that person would get a point for hypertension, they'd get a point for age, and they would get a point for being a female, that's a score of three. Now, you go over here to the Chadsvasc score of three and you can see they are a 3.2 percent stroke risk on a yearly basis. Now that's not zero, it's still one out of thirty three people in that category are having a stroke on an annual basis. But what I try and do is, I try and tell people that I don't want your risk of having a stroke to be three percent, and with a blood thinner, the pharmaceuticals, you can lower that risk down to about one to two percent. Which is still some improvement, but it's not actually getting rid of all risk. And, of course, there is the risk of bleeding on those heavy duty blood thinners. So what do we do? We talk about ways to, number one, eat the right foods, which the people in these studies are not doing. To live the right lifestyle, such as getting sunshine and sleep. And also getting chiropractor care. We talk about staying away from environmental toxins. We talk about getting grounded. We talk about all the things that I talk about in my book, The Pale Cardiologist: The Natural Way to Heart Health. But once again it's about giving people the information. Now you may think, “Hey, the Chdsvasc score of three, three percent, I'm not over concerned with that”. Maybe there are some natural blood thinners that you would be interested in. I use a lot of Nattokinase in my office and vitamin C, and Vitamin E and Garlic. There's a lot of things that, if you help keep the body working appropriately... Even Omega Threes have benefit in this category. If you keep the body working appropriately, your stroke risk is undoubtedly going to be lower. These are just some options for you. This is a fantastic website. This is not a natural website. This is not a holistic website. This is a website created by mainstream cardiologists to get this information out there to the public. Until next time... Contact us : For business inquiries: firstname.lastname@example.org https://www.thedrswolfson.com/ https://www.wolfsonintegrativecardiology.com/ https://www.facebook.com/TheDrsWolfson https://plus.google.com/u/0/+TheDrsWolfson https://twitter.com/thedrswolfson #Healthandwellness #naturalheart #healthcardiology #cardiologistholistic #Hearthealthytips #TheNaturalCardiologist best in Paleo Nutrition and Paleo Lifestyle, Drs. Wolfson,
Просмотров: 3861 The Drs. Wolfson
Dr. Barry Sears Dr. Sears explains how Omega RX fish oil can improve Atrial Fibrillation. Dr. Barry Sears is a leading authority on the impact of the diet on hormonal response, genetic expression, and inflammation. A former research scientist at the Boston University School of Medicine and the Massachusetts Institute of Technology, Dr. Sears has dedicated his research efforts over the past 30 years to the study of lipids. He has published more than 30 scientific articles and holds 13 U.S. patents in the areas of intravenous drug delivery systems and hormonal regulation for the treatment of cardiovascular disease. He has also written 13 books, including the New York Times #1 best-seller "The Zone". These books have sold more than 5 million copies in the U.S. and have been translated into 22 different languages. For more, go to zonediet.com
Просмотров: 32319 Dr. Barry Sears
Mayo Clinic presents Dr. Munger's Avoiding Complications During Atrial Fibrillation Ablation presentation at the 2012 Electrophysiology Review for Boards and Recertification course. We invite you to experience more great presentations at the 2013 Mayo Clinic Electrophysiology Review for Boards and Recertification held August 23-26, in Rochester, Minn. This course will provide the cardiologist or practicing electrophysiologist with an update on the latest knowledge and advances in electrophysiology. The full spectrum of electrophysiology practice will be reviewed, ranging from basic arrhythmia mechanisms and pharmacology, to catheter diagnosis and therapy, and device-based treatments. Although this course is designed specifically to prepare those taking the Cardiovascular Electrophysiology Certification Boards and Recertification Boards, it will also provide the internist or practicing cardiologist with an update on the latest knowledge and advances in electrophysiology. For more information, visit: http://www.mayo.edu/cme/cardiovascular-diseases-2013r134/?mc_id=youtube
Просмотров: 17159 Mayo Clinic
Dr Matthew Fay (GP and AF specialist) and Brendan Young (Patient representative on West Midland Clinical Senate) speak about the importance of anticoagulation for stroke prevention in patients with AF
Просмотров: 808 Stroke Association
Catholic University Medical English
Просмотров: 83 Solange SuRo
http://www.stopafib.org StopAfib.org interviews Dr. Daniel Singer of Harvard Medical School. Find more information on this topic, and Dr. Singer, at: http://www.stopafib.org/newsitem.cfm/NEWSID/397 Dr. Singer led a symposium on atrial fibrillation stroke prevention at Boston Atrial Fibrillation Symposium 2012. In this video interview, Dr. Singer shared with StopAfib.org information from that symposium. He provided an update on rivaroxaban (Xarelto), which was recently approved by the FDA, and talked about the results of the two trials of apixaban (Eliquis), AVERROES and ARISTOTLE, against aspirin and warfarin, respectively. He also mentioned edoxaban, which should finish trials in 2012, and that we now have a year of results in clinical practice with dabigatran (Pradaxa). He also mentioned that the new drugs have all shown better results than warfarin (Coumadin) in preventing intracranial bleeding (bleeding in the brain). He confirmed that patients will have a lot of new choices soon, but that cost will continue to be an issue. Dr. Singer is a Professor of Medicine at Harvard Medical School, Professor of Epidemiology at the Harvard School of Public Health, and Chief of the Clinical Epidemiology Unit at Massachusetts General Hospital.
Просмотров: 3052 StopAfib
http://www.floridainjurylawyer-blog.com/2012/11/the-fda-approved-pradaxa-and.html Many AFib patients take Pradaxa to prevent strokes. Pradaxa injury lawyer Spencer Aronfeld http://bit.ly/RAtNue explains how prescription drug manufacturer Boehringer Ingelheim,spends millions to market Paradaxa to AFib patients. They claim it is a safer and more efficient alternative to Coumadin. They also claimed that Pradaxa did not require the same monitoring as Coumadin and would have fewer food interactions. Unfortunately, Pradaxa is proving to be defective and more dangerous than Coumadin. In its first weeks on the market, there were more than 300 adverse reactions reported to the FDA. By December 2011 over 500 people have reportedly died, mostly from internal bleeding as a result of taking Pradaxa. For more information call: 866-597-4529 or 305-441-0440 Visit: http://www.aronfeld.com/ Facebook: https://www.facebook.com/spencer.aronfeld?v=wall Twitter: http://twitter.com/aronfeld Linkedin: http://www.linkedin.com/in/aronfeld
Просмотров: 4962 Aronfeld Trial Lawyers
Many Americans take blood thinners to help manage atrial fibrillation. AFib, the most common sustained heart arrhythmia, affecting nearly three million people in the United States, can lead to severe complications like strokes if untreated. Ed Cleary came to Massachusetts General Hospital in June 2012 to get his AFib treated. He had tried taking a blood thinner to help manage his AFib, but bled too much. Fortunately, he qualified for a new procedure now being used for the first time in New England by Mass General Hospital. The Lariat® procedure is for patients who cannot be on blood thinners. The procedure, which is minimally-invasive and uses catheters, ties off the left atrial appendage by use of sutures (blood clots often appear in the LAA and can cause strokes). In this video, Moussa Mansour, MD, director of the Mass General Atrial Fibrillation Program in the Institute for Heart, Vascular and Stroke Care, talks about what the procedure does, gives a general overview of the problem for some patients with the left atrial appendage and shares Mr. Cleary's prognosis. For more information about AFib and diseases and conditions treated in the Atrial Fibrillation Program, visit: http://www.massgeneral.org/heartcenter/services/treatmentprograms.aspx?id=1565.
Просмотров: 12167 MassGeneralHospital
Atrial fibrillation is a common heart condition that may lead to congestive heart failure and stroke. Treating atrial fibrillation requires a combination approach of blood thinning and heart rate control. Board certified cardiologist, author and HeartSmartMD co-founder Dr. Matt DeVane gives you a nice overview of the treatment of atrial fibrillation. Learn much more at www.HeartSmartMD.com
Просмотров: 1722 HeartSmartMD
http://www.stopafib.org To be notified when new conference videos are posted, or for the latest afib news, sign up at http://www.stopafib.org 2015 Get in Rhythm. Stay in Rhythm.™ Atrial Fibrillation Patient Conference In the Partnering with Your Healthcare Providers session at the 2015 Get in Rhythm. Stay in Rhythm.™ Atrial Fibrillation Patient Conference, Dr. Robert C. Kowal, MD, PhD, FHRS spoke about getting the most from your doctors, including: • What kind of doctor is likely to manage your care • Doctor taking primary responsibility for your AF depends on how it was discovered [1:38] • Doctor taking primary responsibility based on how you feel [2:09] • What is involved in managing afib care • Care components: stroke prevention, rate management, symptom/rhythm management [3:42] • What prompts referral [4:22] • Patient age, complex medical conditions, history of HD, high heart rate difficult to control, ongoing symptoms despite treatment • AFFIRM trial justifies minimal approach to AF [5:25] • Pieces of atrial fibrillation management [6:40] o Stroke prevention o Rate control o Rhythm management o Timing can be critical o Comorbid conditions • When do patients typically get referred to specialists, and [10:36] • What are the challenges with seeing specialists [11:49] Following Dr. Kowal, Mellanie True Hills discussed communicating with your healthcare providers and resources that can help patients. • Communicating with your doctor [13:59] • Resources – patient care [19:29] • Communications between patients and healthcare providers [20:25] In a subsequent dialogue, Dr. Kowal and Mellanie discussed the following topics: • How to know if you have the right doctor [21:40] • How much variation doctors see in AF patient symptoms [22:32] • What to do if the relationship is just not working [28:30] • What patients do that drive doctors nuts [30:30] • The difficulty of getting patient records [31:55] • How doctors and patients can use mobile health together, and [33:51] • What is the ideal “engaged patient” like [35:43] Video watching time is approximately 45 minutes. Dr. Robert Kowal graduated from Yale University and received his MD and PhD degrees from UT Southwestern Medical Center. He completed his medical internship, residency, and cardiology fellowship at Harvard Medical School/Brigham and Women’s Hospital and went on to study cardiac electrophysiology. He currently practices at Baylor Heart and Vascular Hospital. While performing a broad spectrum of device implantation procedures, from pacemakers to multi-lead defibrillators, his main focus is the management of complex arrhythmias such as atrial fibrillation and ventricular tachycardia. His approaches involve both non-invasive medical therapy and catheter-based ablation procedures. He has been and is currently involved in research on many cutting-edge technologies including cryoballoon ablation and FIRM mapping for atrial fibrillation, left atrial appendage closure and the role of renal denervation in the treatment of arrhythmia. He has taken a national leadership role serving on the Board of Trustees at the Heart Rhythm Society and is on the editorial board of several scientific journals. Transcript http://www.stopafib.org/newsitem.cfm/NEWSID/554/
Просмотров: 1210 StopAfib
Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Some people refer to AF as a quivering heart. An estimated 2.7 million Americans are living with AF.
Просмотров: 22471 American Heart Association
Atrial fibrillation, or AFib, is a common kind of irregular heartbeat that affects millions of people in the United States. If left untreated, AFib can lead to stroke, so it’s important to understand your symptoms and when you should talk to your doctor. Learn more: http://share.upmc.com/2015/04/atrial-fibrillation-mm
Просмотров: 2517 UPMC
Dr. Kneller discusses discuses treatment strategies for atrial fibrillation. Considerations include rhythm control (stopping and preventing atrial fibrillation) and rate control (slowing down the rapid heart rate caused by atrial fibrillation, without attempting to restore a normal rhythm), and whether systemic anticoagulation medication (ie, Xarelto, Eliquis, Pradaxa, or warfarin) is needed. Anti-arrhythmic medications (ie, flecainide, propafenone, sotalol, tikosyn) or catheter ablation are used to restore normal rhythm.
Просмотров: 3340 JamesKnellerMD
http://www.stopafib.org Mellanie True Hills talks about the physical, emotional, and financial impact of atrial fibrillation on patients and their families through sharing her story. Share this with family and friends, and learn more at http://www.StopAfib.org, the atrial fibrillation patient resource
Просмотров: 3774 StopAfib